2023 Annual Conference Recordings - ABSTRACTS: Non-CME - 4/13 3:30 pm - 5:00 pm

Only available as part of a package

This was recorded at the 42nd ASLMS Annual Conference Thursday, April 13th, 3:30PM - 5PM.

Presentations:

CLINICAL TASK PERFORMANCE COMPARISON OF EYE PROTECTION FOR PULSED-DYE LASER APPLICATIONS IN DERMATOLOGY
- Ryan Wilson
EVALUATION OF HOLMIUM LASER LITHOTRIPSY WITH MULTIPLE PULSES
- Youngseok Seo, PhD
USE OF ONABOTULINUM TOXIN A FOR RECALCITRANT FACIAL NEURALGIA ASSOCIATED WITH PARRY-ROMBERG SYNDROME
- Karen Karimi, MD
CLINICAL EVALUATION OF TISSUE MICRO-CORING, A NOVEL TECHNOLOGY FOR TREATING RHYTIDES OF THE SKIN
- Omar Ibrahimi, MD, PhD
LONG-TERM EFFICACY OF FEEDBACK-CONTROLLED 1726NM LASER FOR TREATMENT OF MODERATE INFLAMMATORY ACNE VULGARIS
- Roy Geronemus, MD
FDA ADVISORY PANEL MEMBERS RECOMMEND PROCESS IMPROVEMENTS
- Umer Nadir, BS
OPTIMIZING CLINICAL BENEFIT AND PATIENT EXPERIENCE WITH COMBINATION DEEP TISSUE RADIOFREQUENCY MICRONEEDLE TREATMENT FOLLOWED BY SHALLOW 1927 THULIUM LASER
- Sarah Chapman, MSN, BSN, NP-C
EPIDEMIOLOGY OF PDL AND CO2 TREATMENTS IN THE PEDIATRIC PLASTIC SURGERY AND BURN CENTER IN 2 YEARS PERIOD
- Lidija Barcot
A NEW 532 NM, VARIABLE-PULSE-STRUCTURE, DUAL WAVELENGTH, KTP LASER WITH CRYOGEN SPRAY COOLING EFFECTIVELY TREATS ROSACEA
- Eric Bernstein, MD, MSE
A CLINICAL AND HISTOLOGIC EXAMINATION OF A NEW, HIGH PEAK POWER ND:YAG LASER WITH MICROSECOND TO MILLISECOND PULSE DURATIONS AND UNIQUE SUB PULSE STRUCTURES
- Emil Tanghetti, MD
LIFTING AND CONTOURING OF SOFT FACIAL TISSUE INDUCED BY SIMULTANEOUS APPLICATION OF HIFES AND MONOPOLAR RF
- Brian Kinney, MD, MSME, FACS
THE DESIGN AND EVALUATION OF A NOVEL TOPICAL SERUM DESIGNED TO BE UTILIZED WITH ENERGY-BASED DEVICES FOR PIGMENT CONTROL AND IMPROVEMENT OF SKIN ELASTICITY
- Peter Bjerring, MD, PhD
MODELING THE ACTIVATION OF MOTONEURONS BY AN ELECTROMAGNETIC MUSCLE STIMULATION DEVICE
- Joel Jimenez Lozano, PhD
EXTRACORPOREAL MEMBRANE OXYGENATORS WITH LIGHT DIFFUSING FIBERS FOR TREATMENT OF CARBON MONOXIDE POISONING: EXPERIMENTS, MATHEMATICAL MODELING AND PERFORMANCE ASSESSMENT WITH UNIT CELLS.
- James Childs, PhD
NOVEL DUAL-APPLICATOR CRYOLIPOLYSIS SYSTEM: EVALUATION OF PATIENT-REPORTED SATISFACTION, PSYCHOSOCIAL IMPACT, AND PROCEDURAL ASSESSMENT IN A PROSPECTIVE MULTI-COUNTRY POSTMARKETING STUDY
- Suzanne Kilmer, MD

Jay Bhawalkar (Moderator)

Dr. Jayant Bhawalkar earned a doctoral degree in Physics from the University of Texas at Dallas and subsequently conducted post-doctoral research in the field of Photonics and Non-linear Optics at SUNY, Buffalo. From 2003 to 2017 Dr. Bhawalkar worked at Candela Corporation in various technical and management roles, most recently Vice president of Research, bringing several successful products to the market, among them the first 1064/532nm commercial picosecond laser. Currently, Dr. Bhawalkar is Chief Technology Officer at AVAVA, Inc., a medical device startup company under the umbrella of Blossom Innovations, Inc. He is currently working to bring to market a new class of lasers that could greatly increase safety in skin of color patients. Dr. Bhawalkar has authored several book chapters, over 40 publications, and has over 10 issued patents. He is currently on the Board of the ASLMS as an Industry Representative and serves as a reviewer for the Journal of the ASLMS as well as for journals published by the Optical Society of America. He is a Fellow of the ASLMS and Senior Member of the Optical Society of America.

Brad Hauser (Moderator)

Brad Hauser is currently the Chief Product Officer at the Beauty Health Company and the HydraFacial brand since January 2023. Previously, he was President and CEO of Soliton, Inc. since November 2020. Prior to joining Soliton, Mr. Hauser served as the Vice President, R&D and General Manager for CoolSculpting at Allergan Pharmaceuticals since ZELTIQ Aesthetics, Inc. was acquired by Allergan in April 2017. Previously, he served as the Senior Vice President of Research and Development at ZELTIQ Aesthetics, Inc. from January 2017 to April 2017 and as its Vice President of Research and Development from July 2015 to January 2017. Mr. Hauser joined ZELTIQ in December 2013 as Vice President of Product and Clinical Strategy. Prior to joining ZELTIQ, he held multiple roles in the aesthetic industry, including Executive Vice President of Commercial Operations for Cutera, Director of Research and Development at Medicis and Managing Director of Product and Clinical Marketing at Solta Medical.